Results 171 to 180 of about 1,671 (202)
Some of the next articles are maybe not open access.
New antithrombin‐based anticoagulants
Medicinal Research Reviews, 2003AbstractClinically used anticoagulants are inhibitors of enzymes involved in the coagulation pathway, primarily thrombin and factor Xa. These agents can be either direct or indirect inhibitors of clotting enzymes. Heparin‐based anticoagulants are indirect inhibitors that enhance the proteinase inhibitory activity of a natural anticoagulant ...
openaire +2 more sources
Annales de biologie clinique, 1987
The in vivo regulation of coagulation is mainly controlled by plasma inhibitors in which antithrombin III (AT III) plays an importance role. AT III is a glycoprotein which inhibits all serine proteases, except factor, VIIa, generated during the coagulation process. The proteases are inactivated by formation of an equimolecular complex and this reaction
C, Boyer-Neumann, M, Wolf, M J, Larrieu
openaire +1 more source
The in vivo regulation of coagulation is mainly controlled by plasma inhibitors in which antithrombin III (AT III) plays an importance role. AT III is a glycoprotein which inhibits all serine proteases, except factor, VIIa, generated during the coagulation process. The proteases are inactivated by formation of an equimolecular complex and this reaction
C, Boyer-Neumann, M, Wolf, M J, Larrieu
openaire +1 more source
Rinsho byori. The Japanese journal of clinical pathology, 2011
Toshiaki, Iba, Etsuro, Nakarai
openaire +1 more source
Toshiaki, Iba, Etsuro, Nakarai
openaire +1 more source